DermaSensor completes $5m fundraise following new partnership quadruplet

The Series B financing follows DermaSensor’s establishment of four new partnerships, including a supplier agreement with Henry Schein. The Series B financing follows DermaSensor’s establishment of four new partnerships, including a supplier agreement with Henry Schein. DermaSensor uses a combination of elastic scattering spectroscopy (ESS) and AI to provide risk assessment results for suspicious skin lesions. Credit: Marina Demeshko/Shutterstock.com DermaSensor has raised $5m, with the close of its Series B extension financing round following its establishment of four new partnerships earlier this month. The latest financing tranche for the Miami-based developer of an AI-based skin cancer diagnostic, which featured participation…

Source: Medical Device Network